Last updated on September 2012

Parkinson’s Disease - Mild to moderate symptoms


Brief description of study

Parkinson’s Disease - Mild to moderate symptoms

Detailed Study Description

Parkinson’s disease (PD) affects millions of people all over the world. Dealing with it may seem daunting and frustrating. Medications can help manage some of the symptoms like the shaking and jerking, but over time they may not seem to work as well. We’re conducting a study of an investigational drug for Parkinson’s disease.

As you may know, Parkinson’s disease can become worse over time. This study will monitor the safety and tolerability of a new investigational drug compound called AZD3241. This investigational drug is being developed to see if it can slow the rate at which Parkinson’s disease gets worse over time.

We’re looking for people who might be willing to participate. You may be eligible to participate if you:

  • are 30-80 years old
  • have mild to moderate Parkinson’s disease

If you are currently taking certain medications for your PD (such as L-dopa) you may be able to continue taking them during the study. Our staff will review your medical history and other criteria at the first study visit. The study lasts about 4 months and requires up to 8 visits to the study clinic.

Study procedures include a complete physical examination including tests to ensure that you are in good health. Other testing includes blood and urine samples, ECGs, and evaluations of your Parkinson’s disease symptoms. The study drug is taken twice daily by mouth.

If you qualify, you will be compensated for time and travel and receive all study-related office visits, medical examinations, and investigational medication at no cost.

For more information contact: AdvanceMed Research 609-895-0735

Clinical Study Identifier: TX136256

Contact Investigators or Research Sites near you

Start Over

AdvanceMed Research

AdvanceMed Research
Lawrenceville, NJ USA
  Connect »